Penserra Capital Management LLC Uni Qure N.V. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$20.24 - $36.01 $21,252 - $37,810	-1,050 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$29.97 - $37.17 $1,348 - $1,672	45 Added 4.48%	1,050 $32,000
Q1 2021 May 13, 2021	SELL	$29.24 - $42.03 $584 - $840	-20 Reduced 1.95%	1,005 $33,000
Q4 2020 Feb 12, 2021	BUY	$35.35 - $50.67 $22,871 - $32,783	647 Added 171.16%	1,025 $37,000
Q3 2020 Nov 13, 2020	BUY	$35.98 - $47.66 $13,600 - $18,015	378 New	378 $13,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.